The role of vitamin D supplementation in the risk of developing pneumonia: Three independent case-control studies

Thorax

Volumn 68, Issue 11, 2013, Pages 990-996

  Remmelts, Hilde H F ^a,b,c   Spoorenberg, Simone M C ^a   Oosterheert, Jan Jelrik ^b   Bos, Willem Jan W ^a   De Groot, Mark C H ^d   Van De Garde, Ewoudt M W ^a,d  

^a ST ANTONIUS HOSPITAL   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c GELDERSE VALLEI HOSPITAL   (Netherlands)

^d UTRECHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; VITAMIN D;

ADULT; ARTICLE; ASTHMA; BONE MINERALIZATION; CASE CONTROL STUDY; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG EFFECT; DRUG RESPONSE; FEMALE; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PATIENT ASSESSMENT; PNEUMONIA; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION;

RESPIRATORY INFECTION;

DIETARY SUPPLEMENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FOLLOW-UP STUDIES; HOSPITALIZATION; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NETHERLANDS; PNEUMONIA; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; VITAMIN D; VITAMIN D DEFICIENCY; VITAMINS;

EID: 84885726454     PISSN: 00406376     EISSN: 14683296     Source Type: Journal    
DOI: 10.1136/thoraxjnl-2013-203623     Document Type: Article

References (29)

1. Niederman M. In the clinic. Community-acquired pneumonia. Ann Intern Med 2009;151:ITC4.
2. Lips P. Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications. Endocr Rev 2001;22:477-501. (Pubitemid 32762324)
3. Pearce SH, Cheetham TD. Diagnosis and management of vitamin D deficiency. BMJ 2010;340:b5664.
4. Muhe L, Lulseged S, Mason KE, et al. Case-control study of the role of nutritional rickets in the risk of developing pneumonia in Ethiopian children. Lancet 1997;349:1801-4. (Pubitemid 27257557)
5. Ginde AA, Mansbach JM, Camargo CA Jr. Association between serum 25-hydroxyvitamin D level and upper respiratory tract infection in the Third National Health and Nutrition Examination Survey. Arch Intern Med 2009;169:384-90.
6. Laaksi I. Vitamin D and respiratory infection in adults. Proc Nutr Soc 2012;71:90-7.
7. Berry DJ, Hesketh K, Power C, et al. Vitamin D status has a linear association with seasonal infections and lung function in British adults. Br J Nutr 2011;106:1433-40.
8. Sabetta JR, DePetrillo P, Cipriani RJ, et al. Serum 25-hydroxyvitamin D and the incidence of acute viral respiratory tract infections in healthy adults. PLoS One 2010;5:e11088.
9. Laaksi I, Ruohola JP, Tuohimaa P, et al. An association of serum vitamin D concentrations <40 nmol/L with acute respiratory tract infection in young Finnish men. Am J Clin Nutr 2007;86:714-17. (Pubitemid 47435839)
10. Aranow C. Vitamin D and the immune system. J Investig Med 2011;59:881-6.
11. Urashima M, Segawa T, Okazaki M, et al. Randomized trial of vitamin D supplementation to prevent seasonal influenza A in schoolchildren. Am J Clin Nutr 2010;91:1255-60.
12. Manaseki-Holland S, Qader G, Isaq MM, et al. Effects of vitamin D supplementation to children diagnosed with pneumonia in Kabul: a randomised controlled trial. Trop Med Int Health 2010;15:1148-55.
13. Li-Ng M, Aloia JF, Pollack S, et al. A randomized controlled trial of vitamin D3 supplementation for the prevention of symptomatic upper respiratory tract infections. Epidemiol Infect 2009;137:1396-404.
14. Manaseki-Holland S, Maroof Z, Bruce J, et al. Effect on the incidence of pneumonia of vitamin D supplementation by quarterly bolus dose to infants in Kabul: a randomised controlled superiority trial. Lancet 2012;379:1419-27.
15. Murdoch DR, Slow S, Chambers ST, et al. Effect of vitamin D3 supplementation on upper respiratory tract infections in healthy adults: the VIDARIS randomized controlled trial. JAMA 2012;308:1333-9.
16. Endeman H, Meijvis SC, Rijkers GT, et al. Systemic cytokine response in patients with community-acquired pneumonia. Eur Respir J 2011;37:1431-8.
17. Meijvis SC, Hardeman H, Remmelts HH, et al. Dexamethasone and length of hospital stay in patients with community-acquired pneumonia: a randomised, double-blind, placebo-controlled trial. Lancet 2011;377:2023-30.
18. Stirbu-Wagner I, Dorsman SA, Visscher S, et al. Landelijk Informatienetwerk Huisartsenzorg. Feiten en cijfers over huisartsenzorg in Nederland. Utrecht/ Nijmegen: NIVEL/IQ, 2010. http://www.LINH.nl
19. WHO Collaborating Center for Drug Statistics Methodology. Guidelines for ATC classification and DDD assignment. Oslo: World Health Organization, 2000.
20. Meijvis SC, Cornips MC, Voorn GP, et al. Microbial evaluation of proton-pump inhibitors and the risk of pneumonia. Eur Respir J 2011;38:1165-72.
21. Vestergaard P. Epilepsy, osteoporosis and fracture risk-a meta-analysis. Acta Neurol Scand 2005;112:277-86. (Pubitemid 41530723)
22. Davidson ZE, Walker KZ, Truby H. Clinical review: do glucocorticosteroids alter vitamin D status? A systematic review with meta-analyses of observational studies. J Clin Endocrinol Metab 2012;97:738-44.
23. Lips P. Interaction between vitamin D and calcium. Scand J Clin Lab Invest Suppl 2012;243:60-4.
24. Remmelts HH, van de Garde EM, Meijvis SC, et al. Addition of vitamin D status to prognostic scores improves the prediction of outcome in community-acquired pneumonia. Clin Infect Dis 2012;55:1488-94.
25. Levin GP, Robinson-Cohen C, de Boer IH, et al. Genetic variants and associations of 25-hydroxyvitamin D concentrations with major clinical outcomes. JAMA 2012;308:1898-905.
26. Rejnmark L, Avenell A, Masud T, et al. Vitamin D with calcium reduces mortality: patient level pooled analysis of 70,528 patients from eight major vitamin D trials. J Clin Endocrinol Metab 2012;97:2670-81.
27. Bolland MJ, Grey A, Avenell A, et al. Calcium supplements with or without vitamin D and risk of cardiovascular events: reanalysis of the Women's Health Initiative limited access dataset and meta-analysis. BMJ 2011;342:d2040.
28. van de Garde EM, Deneer VH, Souverein P, et al. Validation of community-acquired pneumonia: high positive predictive value for ICD-9 codes. Pharmacoepidemiol Drug Saf 2008;17:S248.
29. Meropol SB, Metlay JP. Accuracy of pneumonia hospital admissions in a primary care electronic medical record database. Pharmacoepidemiol Drug Saf 2012;21:659-65.